|
|
Factors Related to Poor Prognosis in Patients with Acute Myocardial Infarction Wrongly Activated by Intracardiac Catheterization |
XIONG Zhi-wei |
Xinyang Central Hospital,Xinyang Henan 464000 |
|
|
Abstract 【Objective】 To analyze the related factors that affect the poor prognosis of intraventricular catheterization in patients with acute myocardial infarction (AMI). 【Methods】 A prospective study was conducted on 107 AMI patients admitted to our hospital from May 2019 to February 2022 who were mistakenly activated by intracardiac catheterization. Based on the patient's prognosis,they were divided into an observation group (those with poor prognosis,n=31) and a control group (those with good prognosis,n=76). Clinical data of patients were collected and logistic multiple factor regression analysis was used to analyze the related factors that affect the poor prognosis of cardiac catheterization in AMI patients.【Results】 The incidence of poor prognosis in 107 AMI patients with intracardiac catheter misactivation was 28.97% (31/107). There was a statistically significant difference (P<0.05) between the two groups of patients in terms of cardiovascular risk factors,history of coronary heart disease,previous PCI history,time of first medical contact with the device,left bundle branch block,time of infarcted artery reconstruction,and chest pain symptoms. Logistic regression analysis showed that the time of infarcted artery reconstruction,history of coronary heart disease,previous PCI history,time of first medical contact with the device,left bundle branch block,and chest pain symptoms were the influencing factors for poor prognosis in patients with intracardiac catheter room activation (P<0.05). 【Conclusion】 The poor prognosis of AMI patients with intracardiac catheterization room misactivation is influenced by factors such as infarct artery reconstruction time,history of coronary heart disease,previous PCI history,time of first medical contact with the device,left bundle branch block,chest pain symptoms,etc. Clinical scholars can develop intervention measures based on these factors to reduce the occurrence of adverse cardiovascular events and improve patient prognosis.
|
Received: 13 July 2022
|
|
|
|
|
[1] WANG J.Circulating microRNA-208 family as early diagnostic biomarkers for acute myocardial infarction:A meta-analysis[J].Medicine (Baltimore),2021,100(51):27779. [2] KAPUR N K,THAYER K L,ZWECK E,et al.Cardiogenic Shock in the Setting of Acute Myocardial Infarction[J].Methodist Debakey Cardiovasc J,2020,16(1):16-21. [3] 朱建中,吴倩芸,刘峰,等.急性ST段抬高型心肌梗死“导管室误激活”的临床进展[J].心血管病学进展,2019,40(5):739-744. [4] 徐彬,陈长征,方杰,等.院前急救联合绿色通道模式对急性心肌梗死PPCI术患者救治效果和术后不良心血管事件的影响[J].现代生物医学进展,2021,21(10):1908-1911. [5] 黄爱玲.细节管理在心导管室的应用体会[J].临床医药实践,2018,27(8):629-631. [6] 葛贝贝,许迪,缪长青,等.左束支传导阻滞对左心室功能及运动模式的影响[J].中华超声影像学杂志,2020,29(9):799-806. [7] 元洋洋,龙茸,李坚,等.合并束支传导阻滞的急性心肌梗死患者冠脉病变程度、左心室功能变化观察[J].山东医药,2021,61(30):66-69. [8] 张诗梦,张恒莉,崔畅,等.完全性左束支传导阻滞患者avL导联q波与器质性心脏病相关性的探讨[J].南京医科大学学报(自然科学版),2020,40(4):557-562. [9] 尚珊珊,郭欣,张燕,等.胸痛中心区域协同救治体系对ST段抬高型心肌梗死再灌注时间和预后的影响[J].中国介入心脏病学杂志,2020,28(1):26-30. [10] 叶靖,晏花龙.早期应用替罗非班对急性ST段抬高型心肌梗死患者行急诊经皮冠状动脉介入术疗效影响研究[J].山西医药杂志,2021,50(13):2076-2078. [11] 胡景春,汪永生,洪大付,等.STEMI患者症状至首次医疗接触时间的延迟因素及对直接PCI术临床疗效的影响[J].安徽医学,2021,42(4):436-440. [12] 付丽,王楠,杨柳,等.首次医疗接触至球囊扩张时间对急性ST段抬高型心肌梗死患者心功能的影响[J].中国医药,2018,13(5):667-670. |
[1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2023, 40(5): 777-779. |
|
|
|
|